Synventia Pharma Private Limited - Due diligence report
A 360° intelligence report on Synventia Pharma Private Limited: trust score, financial health, credit view, compliance, directors, growth an…
Synventia Pharma Private Limited — 360° Intelligence Report
Generated from MCA filings & public recordsSynventia Pharma Private Limited is assessed as Low Risk with a Trust Score of 78/100. Synventia Pharma Private Limited is an active private limited indian non-government company incorporated in 2020, operating in the Pharma sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.
Report generated on 13 Jun 2026 from the latest processed filings. Synventia Pharma Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
Standalone · 2 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
Credit & Compliance Intelligence
Why the scores are what they are- Negative operating earnings - debt service depends on external support.
- No open charges - unencumbered balance sheet.
Charges position: 0 open (-) · 0 satisfied (-).
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- 1 active GST registration(s).
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| SRINIVASA RAO PAPINENI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VENU GOPAL VELDI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SURENDAR VELAGAPURI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 3 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Ownership & Group Intelligence
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth 55 · Distress 65Stakeholder Verdicts
Vendor · Banker · Investor- Statutory record is clean.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
- 1 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
MCA Filings & Events Timeline
Latest 7 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| Chemiker Pharmaceuticals Private Limited | U24299MH2018PTC304732 | Butibori, Maharashtra, India |
| Mkv Pharma Private Limited | U51909DL2019PTC349190 | New Delhi, Delhi, India |
| Siddhashram Ayurved And Food Products Private Limited | U74999MP2017PTC043819 | Beohari, Madhya Pradesh, India |
| Btm Healthcare Private Limited | U51397BR2013PTC021059 | Patna, Bihar, India |
| Technovation Healthcare Private Limited | U74120MH2011PTC220586 | Mumbai, Maharashtra, India |
| Bonita Pharmaceuticals | U24239GJ2011PTC067738 | Ahmedabad, Gujarat, India |
| Das Oncocare Private Limited | U74999MH2018PTC313929 | Goregaon E Mumbai, Maharashtra, India |
| Tevos Pharmaceuticals Llp | AAR-9087 | Ahmedabad, Gujarat, India |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Synventia Pharma Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Synventia Pharma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Mixed indicators. Growth score 55/100, margin trends, ownership structure and peer set for Synventia Pharma Private Limited - screening before a deeper diligence.
Vendor verdict: Favourable indicators. Trust score 78/100, distress signals and MSME payment-delay disclosures - know whether Synventia Pharma Private Limited pays its suppliers before you extend credit terms.
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Synventia Pharma Private Limited - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Synventia Pharma Private Limited an active company?
Synventia Pharma Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).
Is Synventia Pharma Private Limited financially healthy?
Synventia Pharma Private Limited has a Financial Health Score of 45/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Synventia Pharma Private Limited?
Its overall Trust Score is 78/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Synventia Pharma Private Limited?
See the directors and ownership sections above for board and shareholding detail. 3 active director(s) are on record.
Does Synventia Pharma Private Limited have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Synventia Pharma Private Limited up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).
Is it risky to lend to Synventia Pharma Private Limited?
Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.